Vicore Pharma Holding AB
556680-3804ActiveDeveloping novel ATRAG drugs for severe respiratory diseases.
Oversikt
- 5–9
- Ansatte
- 100–500mill SEK
- Omsetning
- 2005
- Grunnlagt
Beskrivelse
Vicore is an innovative, clinical-stage pharmaceutical company focused on developing life-changing treatments for severe diseases where the AT2 receptor plays a central role. Their primary ambition is unlocking the potential of Angiotensin II Type 2 Receptor Agonists (ATRAGs), a new class of drugs w...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Verksamheter som utövas av huvudkontor
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556680380401
Beslutningstakere
Ingen beslutningstakere funnet ennå
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
CALLUNA PHARMA AS
10 ansatteClinical stage biotech pioneering antibodies for inflammation and fibrosis.
Melius Pharma AB
0 ansatteSwedish clinical-stage pharma developing low-risk IPF cough treatment.
DiaBridge AB
0 ansatteDeveloping breakthrough drugs targeting DNA repair for cancer and inflammation.
Cereno Scientific AB
10–19 ansattePioneering disease-modifying treatments for rare cardiovascular and pulmonary diseases.
Cinclus Pharma Holding AB (publ)
20–49 ansatteSwedish clinical-stage pharma developing superior GERD treatment drug candidate.
Utforsk mer
Spørsmål om Vicore Pharma Holding AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo